Back to Search
DAVID HAUPT, MD
MD
Specialist
NPI: 1902886419Individual
Specialties, Licenses & Credentials
Research & Publications (19)
Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents.
PMID 19147694·Am J Psychiatry·2009
8-other
Impact of medical comorbidity on medication management of schizophrenia.
PMID 18389928·CNS Spectr·2007
6-review
Metabolic risks and effects of atypical antipsychotic treatment.
PMID 17960957·J Clin Psychiatry·2007
8-other
Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients.
PMID 17375138·Neuropsychopharmacology·2007
8-other
Differential metabolic effects of antipsychotic treatments.
PMID 16872808·Eur Neuropsychopharmacol·2006
6-review
Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
PMID 15367925·Neuropsychopharmacology·2005
3-trial
Abnormalities in glucose regulation associated with mental illness and treatment.
PMID 12377305·J Psychosom Res·2002
6-review
Dispensed volumes of anti-asthmatic drugs related to the prevalence of asthma and COPD in Sweden.
PMID 18302301·Pharmacoepidemiol Drug Saf·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1550 BOYSON RD
HIAWATHA, IA 52233 - Phone
- (319) 743-7300
Quick Facts
- NPI
- 1902886419
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile